Cited by 45

The DOI matches its Crossref record.

MALAT1 promotes the colorectal cancer malignancy by increasing DCP1A expression and miR203 downregulation

Wu, Chuanqing, Zhu, Xiaojie, Tao, Kaixiong, Liu, Weizhen, Ruan, Tuo, Wan, Wenze, Zhang, Chun, Zhang, Weikang·2018·Molecular Carcinogenesis

Abstract

The long non‐coding RNA MALAT1 has been proved to promote the cell proliferation, drug resistance, invasion, and metastasis of colorectal cancer (CRC) in vitro and in vivo by regulating the expression of various oncogenes and their protein products. Our previous work discovered that the expression of the mRNA‐decapping enzymes 1a (DCP1A) is upregulated in CRCs. However, the relationships between MALAT1 and DCP1A in the development of CRC and the underlying mechanisms are still unclear. In this study, we investigated the molecular mechanisms by which MALAT1 and DCP1A may be linked to contribute to the malignancies of CRCs. We found that DCP1A is a direct target molecule of MALAT1. Moreover, by screening the downstream genes of MALAT1, we noticed that microRNA 203(miR203), an oncogene suppressor in numerous cancers, is inversely correlated to both MALAT1 and DCP1A expressions. Following MALAT1 knockdown, we observed overexpression of miR203 accompanied with DCP1A downregulation to a level that reversed the promoted cell proliferation, invasion, and migration in vitro and in vivo, which could be restored by miR203 knockdown or DCP1A overexpression. These results proposed a new molecular mechanism of MALAT‐miR203‐DCP1A axis which is involved with the development and contributes to the malignancy of colorectal cancers.

Overview

Integrity signals

Registry

Crossref · 10.1002/mc.22868

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 46

  1. 10.1002/jcp.24918 · DOI
  2. 10.1007/s12253-015-9960-5 · DOI
  3. 10.1002/ijc.28557 · DOI
  4. 10.1186/1471-2164-14-589 · DOI
  5. 10.1016/j.humpath.2009.09.019 · DOI
  6. 10.1016/j.cellsig.2017.04.020 · DOI
  7. 10.18632/oncotarget.16339 · DOI
  8. 10.1016/j.canlet.2017.05.024 · DOI
  9. 10.1371/journal.pone.0049783 · DOI
  10. 10.1371/journal.pone.0061697 · DOI
  11. 10.1371/journal.pone.0123223 · DOI
  12. 10.1097/CMR.0000000000000406 · DOI
  13. 10.1002/ijc.30409 · DOI
  14. Qiao L, 2017, Down regulation of the long non‐coding RNA PCAT‐1 induced growth arrest and apoptosis of colorectal cancer cells, Life Sci, 38, 257
  15. 10.1007/s10529-017-2392-4 · DOI
  16. Zhu W, 2017, Knockdown of lncRNA HNF1A‐AS1 inhibits oncogenic phenotypes in colorectal carcinoma, Mol Med Rep, 12, 6626
  17. 10.1016/j.biopha.2017.07.056 · DOI
  18. Peng WX, 2017, LncRNA‐mediated regulation of cell signaling in cancer, Oncogene, 27, 4615
  19. 10.1111/cpr.12312 · DOI
  20. 10.1016/j.brainresbull.2017.03.010 · DOI
  21. 10.1111/jcmm.13101 · DOI
  22. 10.1080/15384101.2017.1361072 · DOI
  23. 10.1016/j.celrep.2017.08.041 · DOI
  24. 10.1038/s41598-017-10869-y · DOI
  25. 10.1159/000480419 · DOI
  26. He B, 2017, LncRNA SNHG5 regulates imatinib resistance in chronic myeloid leukemia via acting as a CeRNA against MiR‐205‐5p, Am J Cancer Res, 7, 1704
  27. 10.1038/sj.onc.1207219 · DOI
  28. 10.1016/j.biopha.2017.07.005 · DOI
  29. 10.1002/gcc.22332 · DOI
  30. 10.1177/1010428317719869 · DOI
  31. 10.1038/modpathol.2017.35 · DOI
  32. 10.1371/journal.pone.0073268 · DOI
  33. 10.1016/j.scr.2013.09.011 · DOI
  34. 10.1158/1535-7163.MCT-16-0591 · DOI
  35. Jin Y, 2017, LncRNA MALAT1 promotes proliferation and metastasis in epithelial ovarian cancer via the PI3K‐AKT pathway, Eur Rev Med Pharmacol Sci, 21, 3176
  36. 10.3390/ijms16046677 · DOI
  37. 10.1002/ijc.30409 · DOI
  38. 10.1371/journal.pone.0061697 · DOI
  39. 10.1371/journal.pone.0049783 · DOI
  40. 10.1111/jcmm.12940 · DOI
  41. 10.1016/j.molimm.2015.01.019 · DOI
  42. 10.1016/j.taap.2014.04.020 · DOI
  43. 10.3892/ijo.2014.2365 · DOI
  44. 10.3892/mmr.2015.4013 · DOI
  45. Liang M, 2015, Downregulation of miR203 induces overexpression of PIK3CA and predicts poor prognosis of gastric cancer patients, Drug Des Devel Ther, 9, 3607
  46. 10.1158/1535-7163.MCT-16-0591 · DOI

Cited by

Sorted by citations

See all 45

Metadata

Authors
Wu, C., Zhu, X., Tao, K., Liu, W., Ruan, T., Wan, W., Zhang, C., & Zhang, W.
Affiliations
  • Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan China
  • Department of Hematology, Union Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan China
Venue
Molecular Carcinogenesis
Publisher
Wiley
Published
2018-07-12
Volume
57
Issue
10
Pages
1421-1431
ISSN
  • 0899-1987
  • 1098-2744
Cited by
45
References
0
Language
en
Funders
  • Natural Science Foundation of Hubei Province (2017CFB474)
  • National Natural Science Foundation of China (81600401)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review